Most Clicked StoriesMore >


Report: Global pharmaceutical sales hit record high in 2013

BIO SmartBrief | Sep 15, 2014

A report from Thomson Reuters' CMR International unit showed global drug sales reached a high of about $980 billion last year and could increase to $1 trillion this year. The number of new molecular entities approved in the U.S., however, dropped by more than 30% from 2012 to 2013. Despite the decline in approval rate, 27 NMEs were commercialized in 2013, marking the second-highest number since 2008, data suggest. Outsourced Pharma (09/12)


Merck unit, Sutro sign antibody-drug development pact worth over $298M

BIO SmartBrief | Sep 18, 2014

AstraZeneca-Lilly's Alzheimer's drug pact could be worth $500M

BIO SmartBrief | Sep 17, 2014

Gilead licenses hep C drug Sovaldi to 7 Indian generic-drug firms

BIO SmartBrief | Sep 16, 2014

Stem cell research offers hope, hype

BIO SmartBrief | Sep 17, 2014

Greenwood: Increased offering ceiling under JOBS Act will help biotechs

BIO SmartBrief | Sep 19, 2014

Regeneron drug wins FDA breakthrough status for diabetic retinopathy

BIO SmartBrief | Sep 18, 2014

Pharma deserves appreciation, not criticism amid Ebola outbreak

BIO SmartBrief | Sep 15, 2014

Baxter-Halozyme immunodeficiency drug HyQvia gains FDA approval

BIO SmartBrief | Sep 15, 2014

Cellerant wins $47.5M to develop stem cell therapy for radiation poisoning

BIO SmartBrief | Sep 15, 2014


Find BIO SmartBrief Issues by Date:



BIO News More >


Summer 2014 BIO Therapeutic Newsletters

BIO SmartBrief | Sep 19, 2014

Registration is open for the BIO Investor Forum!

BIO SmartBrief | Sep 18, 2014

New BIO Survey Tool: FDA/Sponsor Interactions During Drug Development

BIO SmartBrief | Sep 17, 2014

Industrial biotechnology with a French twist!

BIO SmartBrief | Sep 16, 2014

Housing & registration open for the BIO Pacific Rim Summit

BIO SmartBrief | Sep 15, 2014




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more